Search results
Results from the WOW.Com Content Network
Some azole drugs may disrupt estrogen production in pregnancy, affecting pregnancy outcome. [26] Oral fluconazole is not associated with a significantly increased risk of birth defects overall, although it does increase the odds ratio of tetralogy of Fallot, but the absolute risk is still low. [27] Women using fluconazole during pregnancy have ...
In pregnancy, higher levels of estrogen make a woman more likely to develop a yeast infection. During pregnancy, the Candida fungus is more common, and recurrent infection is also more likely. [2] There is tentative evidence that treatment of asymptomatic candidal vulvovaginitis in pregnancy reduces the risk of preterm birth. [17]
In pregnancy, use on the skin or in the vagina is believed to be safe. [2] There is no evidence of harm when used by mouth during pregnancy but this has been less well studied. [2] When used by mouth, greater care should be taken in those with liver problems. [2] It is in the azole class of medications and works by disrupting the fungal cell ...
Candidiasis is a fungal infection due to any species of the genus Candida (a yeast). [4] When it affects the mouth, in some countries it is commonly called thrush. [3] Signs and symptoms include white patches on the tongue or other areas of the mouth and throat. [3]
Itraconazole is a relatively well-tolerated drug (although not as well tolerated as fluconazole or voriconazole) and the range of adverse effects it produces is similar to the other azole antifungals: [22] elevated alanine aminotransferase levels are found in 4% of people taking itraconazole
The study found that male mice treated with the compound exhibited “normal mating behavior” but resulted in zero pregnancies, whereas male mice given a placebo impregnated their mates 30% of ...
The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." Prescriptions for weight loss drugs are skyrocketing, especially among ...
A men's birth control gel has returned promising results in phase 2 trials, but a lack of funding for further testing is a major hurdle.